WallStreetZenWallStreetZen

NASDAQ: CPRX
Catalyst Pharmaceuticals Inc Stock Ownership - Who owns Catalyst Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Catalyst Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Preethi SundaramChief Strategy Officer2025-06-111,600$26.42
$42.27kSell
Preethi SundaramChief Strategy Officer2025-06-102,324$26.41
$61.38kSell
Patrick J. McEnanyDirector2025-06-09171,748$26.11
$4.48MSell
Patrick J. McEnanyDirector2025-06-0628,252$25.95
$733.00kSell
Richard J. DalyPresident and CEO2025-05-3070,000$24.86
$1.74MSell
Gary IngenitoChief Med. Reg. Officer2025-05-1444,000$23.63
$1.04MSell
Gary IngenitoChief Med. Reg. Officer2025-05-1444,000$4.64
$204.16kBuy
Gary IngenitoChief Med. Reg. Officer2025-05-13200,000$3.42
$684.00kBuy
Gary IngenitoChief Med. Reg. Officer2025-05-13200,000$23.68
$4.74MSell
Gary IngenitoChief Med. Reg. Officer2025-03-06180,096$2.24
$403.42kBuy

1 of 6

CPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CPRX insiders and whales buy or sell their stock.

CPRX Shareholders

What type of owners hold Catalyst Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc15.42%18,804,335$398.28MInstitution
Vanguard Group Inc6.97%8,495,580$179.94MInstitution
Biomarin Pharmaceutical Inc5.47%6,666,667$141.20MInsider
State Street Corp4.53%5,530,437$117.13MInstitution
Patrick J. McEnany3.87%4,719,467$99.96MInsider
Hubert E. Md Huckel3.11%3,793,238$80.34MInsider
Deerfield Management Company LP Series C2.81%3,422,149$72.48MInstitution
Goldman Sachs Group Inc2.57%3,135,473$66.41MInstitution
Renaissance Technologies LLC2.42%2,956,316$62.61MInstitution
Geode Capital Management LLC2.27%2,765,556$58.57MInstitution

1 of 3

CPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CPRX80.46%15.82%Net SellingNet Selling
MIRM50.92%49.08%Net SellingNet Selling
ARWR74.85%9.93%Net Selling
RARE84.71%15.29%Net SellingNet Selling
LGND16.92%83.08%Net SellingNet Buying
View Top Biotech Stocks

Catalyst Pharmaceuticals Stock Ownership FAQ

Who owns Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals (NASDAQ: CPRX) is owned by 80.46% institutional shareholders, 15.82% Catalyst Pharmaceuticals insiders, and 3.72% retail investors. Biomarin Pharmaceutical Inc is the largest individual Catalyst Pharmaceuticals shareholder, owning 6.67M shares representing 5.47% of the company. Biomarin Pharmaceutical Inc's Catalyst Pharmaceuticals shares are currently valued at $143.00M.

If you're new to stock investing, here's how to buy Catalyst Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.